Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
China
· Delayed Price · Currency is CNY 19.91
-0.16 (-0.80%)
Apr 30, 2026, 9:55 AM CST
SHA:688687 Revenue
Beijing Kawin Technology Share-Holding had revenue of 206.89M CNY in the quarter ending March 31, 2026, a decrease of -10.67%. This brings the company's revenue in the last twelve months to 1.30B, up 3.75% year-over-year. In the year 2025, Beijing Kawin Technology Share-Holding had annual revenue of 1.32B with 7.35% growth.
Revenue (ttm)
1.30B
Revenue Growth
+3.75%
P/S Ratio
2.59
Revenue / Employee
2.16M
Employees
600
Market Cap
3.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.32B | 90.49M | 7.35% |
| Dec 31, 2024 | 1.23B | -181.71M | -12.87% |
| Dec 31, 2023 | 1.41B | 252.03M | 21.73% |
| Dec 31, 2022 | 1.16B | 15.62M | 1.36% |
| Dec 31, 2021 | 1.14B | 282.30M | 32.75% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novoprotein Scientific | 146.44M |
| Guangdong VTR Bio-Tech | 832.26M |
| Yantai Zhenghai Biotechnology | 347.75M |
| Zhejiang Shouxiangu Pharmaceutical | 640.18M |
| Shenzhen Bioeasy Biotechnology | 271.53M |
| Shanghai Model Organisms Center | 421.02M |
| Landfar Bio-medicine | 415.94M |
| Shanghai Shen Lian Biomedical | 288.27M |